冠心病合并中度缺血性二尖瓣关闭不全:CABG联合MVP与单纯CABG的倾向性评分匹配对比
结果显示两组围手术期病死率及并发症无差异,远期总体生存率和无主要不良心脑血管事件生存率相似;联合MVP能更好改善二尖瓣反流,但手术时间、ICU停留、术后住院时间及血液制品用量增加。
要点
- CABG联合MVP与单纯CABG的全因病死率和主要不良心脑血管事件生存率相似。
- 联合MVP能更好地改善二尖瓣反流,但手术时间、ICU停留和术后住院时间更长。
- 联合MVP的悬浮红细胞和血小板用量明显增加。
核心结论
- 对于冠心病合并中度缺血性二尖瓣关闭不全,CABG联合MVP与单纯CABG的全因病死率和主要不良心脑血管事件发生率相似。
- 联合MVP虽能更好地改善二尖瓣反流,但增加手术时间、ICU停留时间、术后住院时间和血液制品用量。
研究设计与样本
- 按手术方式分为CABG+MVP组和CABG组,采用倾向性评分匹配法1∶4匹配,匹配后联合组107例、CABG组406例。
主要发现
- 两组围手术期病死率和术后并发症发生率无明显差异(P值均>0.05)。
- 联合组手术时间(5.6±1.2)h比(4.2±1.0)h、ICU停留时间43.0(47.3)h比25.0(33.6)h、术后住院时间8(4)d比7(5)d均更长。
- 联合组悬浮红细胞用量2.0(6.5)单位比0(2.0)单位、血小板用量0(0.5)单位比0(0)单位均明显增加。
- 随访32(31)个月,两组总体生存率和无主要不良心脑血管事件生存率无差异(P=0.196,P=0.305)。
- 随访1年、3年超声心动图显示两组射血分数和左心室舒张末内径无差异,但联合手术改善二尖瓣反流更优(F=160.222,P<0.01)。
关键数值与推荐
- 匹配后联合组107例,CABG组406例。
- 随访率93.9%(463/493),随访时间32(31)个月(范围:3~105个月)。
临床怎么用
- 对于冠心病合并中度缺血性二尖瓣关闭不全,选择单纯CABG或联合MVP需权衡二尖瓣反流改善与手术时间、ICU停留、住院时间及血液制品用量增加的风险。
局限性
- 本研究为单中心回顾性分析,结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To compare the efficacy of off-pump coronary artery bypass grafting (CABG) or CABG plus mitral valve plasty (MVP) in patients with coronary heart disease complicated with moderate ischemic mitral insufficiency. Methods: The clinical data of 1 050 patients with coronary heart disease complicated with moderate ischemic mitral insufficiency who underwent surgical procedures from January 2009 to December 2020 were analyzed retrospectively. There were 733 males and 317 females, aging (63.3±9.0) years (range: 31 to 83 years). Patients were divided into CABG+MVP group and CABG group according to surgical methods, and the two groups of patients were matched for 1∶4 by the propensity score matching method. There were 107 patients in the CABG+MVP group and 406 patients in the CABG group after matching. The t test, Mann-Whitney U test, χ2 test, Fisher's exact probability method and repeated measures anova were used to compare the surgical outcomes and overall survival in the two groups. Results: There were no significant differences in perioperative death and postoperative complications between the two groups (all P>0.05). Compared with CABG group, CABG+MVP group had longer operation time ((5.6±1.2) hours vs. (4.2±1.0) hours, t=11.528, P<0.01), ICU stay(M(IQR))(43.0(47.3) hours vs. 25.0(33.6) hours, Z=2.483, P=0.013), and postoperative hospital stay (8(4) days vs. 7(5) days, Z=2.143, P=0.032). The amount of erythrocyte and platelet used in CABG+MVP group was significantly increased (2.0(6.5) U vs. 0(2.0) U, Z=7.084, P<0.01; 0(0.5) U vs. 0(0) U, Z=5.210, P<0.01). A total of 463 cases (93.9%) were followed up. Median follow-up was 32(31) months (range: 3 to 105 months). There was no significant difference in overall survival and no major adverse cardic and cerebrovascular events survival between CABG group and CABG+MVP group (P=0.196,P=0.305). Echocardiography showed that there was no significant difference in ejection fraction left ventricular end-diastolic diameter between the two groups (F=0.322, P=0.571; F=0.681, P=0.410). However, CABG+MVP improved mitral regurgitation better than CABG (F=160.222, P<0.01). Conclusions: For patients with coronary heart disease with moderate ischemic mitral insufficiency, the rates of all-cause mortality and major adverse cardiac and cerebrovascular events are similar between the two surgeries. Although CABG+MVP improves mitral regurgitation better than CABG, it increases the duration of surgery, ICU stay, postoperative hospital stay, and blood transfusion requirement. 目的: 比较非体外循环冠状动脉旁路移植术(CABG)和CABG联合二尖瓣成形术(MVP)治疗冠心病合并中度缺血性二尖瓣关闭不全的效果。 方法: 回顾性分析2009年1月至2020年12月在首都医科大学附属北京安贞医院心脏外科诊断为冠心病合并中度二尖瓣关闭不全并接受外科手术的1 050例患者的临床资料。男性733例,女性317例,年龄(63.3±9.0)岁(范围:31~83岁)。按照手术方式将患者分为联合组(CABG+MVP)和CABG组(非体外循环CABG),采用倾向性评分匹配法对两组患者进行1∶4匹配,匹配后联合组107例,CABG组406例。采用t检验、Mann-Whitney U检验、χ²检验、Fisher确切概率法或重复测量方差分析比较匹配后两组患者的手术情况及远期结局。 结果: 两组的围手术期病死率和术后并发症发生率无明显差异(P值均>0.05)。联合组较CABG组的手术时间[(5.6±1.2)h比(4.2±1.0)h,t=11.528,P<0.01]、ICU停留时间[M(IQR)][43.0(47.3)h比25.0(33.6)h,Z=2.483,P=0.013]和术后住院时间[8(4)d比7(5)d,Z=2.143,P=0.032]更长,悬浮红细胞、血小板用量明显增加[2.0(6.5)单位比0(2.0)单位,Z=7.084,P<0.01;0(0.5)单位比0(0)单位,Z=5.210,P<0.01]。463例获得随访,随访率为93.9%(463/493)。随访时间为32(31)个月(范围:3~105个月)。CABG组和联合手术组的总体生存率和无主要不良心脑血管事件生存率无差异(P=0.196,P=0.305);随访1年、3年超声心动图结果显示,两组射血分数、左心室舒张末内径无差异(F=0.322,P=0.571;F=0.681,P=0.410),但联合手术较CABG能更好地改善二尖瓣反流(F=160.222,P<0.01)。 结论: 非体外循环CABG和CABG联合MVP治疗冠心病合并中度二尖瓣关闭不全,手术全因病死率和主要不良心脑血管事件发生率相似。虽然联合手术较单纯CABG能更好地改善二尖瓣反流,但联合手术的手术时间、ICU停留时间、术后住院时间更长,血液制品用量更多。.
引用
- Fu W, Zhang K, Wang M, et al. [Comparison of off-pump coronary artery bypass grafting alone or combined with mitral valve plasty for coronary heart disease with moderate ischemic mitral insufficiency]. Zhonghua Wai Ke Za Zhi. 2022. PMID: 35790530. doi:10.3760/cma.j.cn112139-20211021-00495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。